Singapore markets close in 7 hours 2 minutes

DiaMedica Therapeutics Inc. (DMAC)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.3800-0.2900 (-10.86%)
At close: 04:00PM EST
2.4300 +0.05 (+2.10%)
After hours: 06:11PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 101.00M
Enterprise value 52.97M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.15
Enterprise value/revenue N/A
Enterprise value/EBITDA -3.62

Trading information

Stock price history

Beta (5Y monthly) 2.41
52-week change 3-68.53%
S&P500 52-week change 314.24%
52-week high 310.8800
52-week low 32.2000
50-day moving average 33.6538
200-day moving average 35.0612

Share statistics

Avg vol (3-month) 3169.01k
Avg vol (10-day) 3107.27k
Shares outstanding 526.44M
Implied shares outstanding 6N/A
Float 819.36M
% held by insiders 121.15%
% held by institutions 120.34%
Shares short (30 Dec 2021) 461.47k
Short ratio (30 Dec 2021) 40.37
Short % of float (30 Dec 2021) 40.23%
Short % of shares outstanding (30 Dec 2021) 40.23%
Shares short (prior month 29 Nov 2021) 450.87k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 314 Nov 2018
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 314 Nov 2018

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sep 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-22.94%
Return on equity (ttm)-37.88%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -14.64M
Net income avi to common (ttm)-14.55M
Diluted EPS (ttm)-0.7720
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)48.1M
Total cash per share (mrq)1.82
Total debt (mrq)68k
Total debt/equity (mrq)0.14
Current ratio (mrq)29.89
Book value per share (mrq)1.78

Cash flow statement

Operating cash flow (ttm)-12.46M
Levered free cash flow (ttm)-7.21M